KR100963227B1 - Composition containing fermented extract of medicinal plant for prevention or relief of alcoholic hangover and manufacturing method thereof - Google Patents
Composition containing fermented extract of medicinal plant for prevention or relief of alcoholic hangover and manufacturing method thereof Download PDFInfo
- Publication number
- KR100963227B1 KR100963227B1 KR1020090065263A KR20090065263A KR100963227B1 KR 100963227 B1 KR100963227 B1 KR 100963227B1 KR 1020090065263 A KR1020090065263 A KR 1020090065263A KR 20090065263 A KR20090065263 A KR 20090065263A KR 100963227 B1 KR100963227 B1 KR 100963227B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- fermentation
- weight
- parts
- hangover
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 54
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 230000002265 prevention Effects 0.000 title claims description 11
- 206010001623 Alcoholic hangover Diseases 0.000 title description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 77
- 238000000855 fermentation Methods 0.000 claims abstract description 63
- 230000004151 fermentation Effects 0.000 claims abstract description 63
- 206010019133 Hangover Diseases 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 15
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 241000186660 Lactobacillus Species 0.000 claims abstract description 6
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 5
- 241000196324 Embryophyta Species 0.000 claims description 34
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 34
- 239000000419 plant extract Substances 0.000 claims description 34
- 241000894006 Bacteria Species 0.000 claims description 21
- 239000004310 lactic acid Substances 0.000 claims description 17
- 235000014655 lactic acid Nutrition 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 16
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 12
- 240000006891 Artemisia vulgaris Species 0.000 claims description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 11
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 10
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 10
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 10
- 229940010454 licorice Drugs 0.000 claims description 10
- 241000202807 Glycyrrhiza Species 0.000 claims description 9
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 241000186000 Bifidobacterium Species 0.000 claims description 2
- 241000192001 Pediococcus Species 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 244000241838 Lycium barbarum Species 0.000 claims 3
- 244000170916 Paeonia officinalis Species 0.000 claims 3
- 235000014443 Pyrus communis Nutrition 0.000 claims 2
- 241000233866 Fungi Species 0.000 claims 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 abstract description 36
- 102000007698 Alcohol dehydrogenase Human genes 0.000 abstract description 35
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 abstract description 35
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 abstract description 34
- 244000241872 Lycium chinense Species 0.000 abstract description 8
- 240000004371 Panax ginseng Species 0.000 abstract description 6
- 235000008434 ginseng Nutrition 0.000 abstract description 6
- 241000092668 Artemisia capillaris Species 0.000 abstract description 2
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract description 2
- 235000008584 Hovenia dulcis Nutrition 0.000 abstract description 2
- 244000010000 Hovenia dulcis Species 0.000 abstract description 2
- 241001532026 Liriope muscari Species 0.000 abstract description 2
- 244000236658 Paeonia lactiflora Species 0.000 abstract description 2
- 241001499733 Plantago asiatica Species 0.000 abstract description 2
- 241000222341 Polyporaceae Species 0.000 abstract description 2
- 241000219780 Pueraria Species 0.000 abstract description 2
- 230000004913 activation Effects 0.000 abstract 2
- 240000006439 Aspergillus oryzae Species 0.000 abstract 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 241001412304 Ixeris Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 241001474977 Palla Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 41
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 32
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- 239000000047 product Substances 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 241000736199 Paeonia Species 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 6
- 235000015468 Lycium chinense Nutrition 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 description 2
- 101000782236 Bothrops leucurus Thrombin-like enzyme leucurobin Proteins 0.000 description 2
- 241001107116 Castanospermum australe Species 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 2
- 241000290083 Leuconostoc lactis KCTC 3528 = DSM 20202 Species 0.000 description 2
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 2
- 244000057717 Streptococcus lactis Species 0.000 description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 2
- 235000021279 black bean Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940107131 ginseng root Drugs 0.000 description 2
- 239000007986 glycine-NaOH buffer Substances 0.000 description 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 108010033145 microsomal ethanol-oxidizing system Proteins 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012453 sprague-dawley rat model Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000018865 Angelica gigas Nutrition 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 241000533367 Cnidium officinale Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 238000001061 Dunnett's test Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000275701 Geranium nepalense Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241001412277 Ixeridium dentatum Species 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 244000215554 Nepeta hederacea Species 0.000 description 1
- 235000011755 Nepeta hederacea Nutrition 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 241000534017 Saururus chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 244000261559 Smilax china Species 0.000 description 1
- 235000000485 Smilax china Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241001300088 Ulmus macrocarpa Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Addiction (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 약용식물 추출 발효물을 유효성분으로 함유하는 숙취 예방 또는 해소용 조성물 및 그 제조방법에 관한 것으로, 보다 상세하게는 인체에 부작용이 없으면서, 알코올 탈수소효소(Alcohol dehydrogenase, ADH) 활성을 저해하면서 알데하이드 탈수소효소(Aldehyde dehydrogenase, ALDH) 활성을 촉진하여 숙취 예방 또는 해소효과가 뛰어난 약용식물 추출 발효물을 유효성분으로 함유하는 숙취 예방 또는 해소용 조성물 및 제조방법에 관한 것이다.The present invention relates to a composition for preventing or eliminating hangovers containing medicinal plant extract fermentation as an active ingredient, and more particularly, to inhibiting alcohol dehydrogenase (ADH) activity without adverse effects on the human body. While promoting the activity of aldehyde dehydrogenase (Aldehyde dehydrogenase, ALDH) to hangover prevention or hangover prevention and remedy composition and manufacturing method containing the medicinal plant extract fermentation with excellent effect as an active ingredient.
알코올은 현대인의 스트레스 해소를 위해 소비가 급증하고 있는 추세이지만, 급성 알코올성 숙취로 인한 메스꺼움, 구토, 현기증, 갈증, 무기력, 두통, 근육통 등의 증상은 업무 능률 저하로 인한 사회경제적 손해를 초래하고 있으며, 만성적인 알코올 섭취 시에는 췌장염, 심근경색, 신경장애, 결핵 등의 장애가 나타나고 나아가 간조직의 구조 및 기능에 치명적인 손상을 초래하게 된다.Although alcohol consumption is increasing rapidly to relieve stress of modern people, symptoms such as nausea, vomiting, dizziness, thirst, lethargy, headache and muscle pain caused by acute alcoholic hangover are causing socioeconomic damages due to decreased work efficiency. In chronic alcohol intake, pancreatitis, myocardial infarction, neurological disorders, tuberculosis, and other disorders appear, leading to fatal damage to liver structure and function.
알코올은 간에서 알코올 탈수소효소(Alcohol dehydrogenase, ADH), 마이크로좀 에탄올 산화계(microsomal ethanol oxidizing system; MEOS) 및 과산화효소(perocidase) 에 의하여 빠르게 아세트알데하이드(acetaldehyde)로 대사되는데 간에서 알콜이 주는 영향보다는 알콜대사물질인 아세트알데하이드(acetaldehyde)가 주는 영향이 더 큰 것으로 알려져있다.Alcohol is rapidly metabolized to acetaldehyde by the liver by alcohol dehydrogenase (ADH), microsomal ethanol oxidizing system (MEOS) and perocidase, rather than the effect of alcohol on the liver. It is known that the effect of acetaldehyde, an alcohol metabolite, is greater.
한편, 아세트알데하이드(acetaldehyde)는 알데하이드 탈수소효소(Aldehyde dehydrogenase, ALDH)에 의해 아세트산(acetic acid)으로 산화됨으로써 아세트알데하이드(acetaldehyde) 축적과 그에 따른 부작용을 방지할 수 있기 때문에, 숙취해소효과를 확인하기 위해서는 알코올 탈수소효소(Alcohol dehydrogenase, ADH)와 함께 알데하이드 탈수소효소(Aldehyde dehydrogenase, ALDH)의 활성에 대한 영향을 함께 검토할 필요가 있다.Meanwhile, acetaldehyde is oxidized to acetic acid by aldehyde dehydrogenase (ALDH) to prevent acetaldehyde accumulation and its side effects. To this end, it is necessary to examine the effects of aldehyde dehydrogenase (ALDH) together with alcohol dehydrogenase (ADH).
최근 음주 후 발생하는 숙취 감소 및 제거를 위한 의약품이 개발되었으나 이들 자체의 독성이나 부작용으로 인해 보다 안전한 천연물 유래 건강음료의 개발에 많은 관심이 모아지고 있다.Recently, drugs for reducing and eliminating hangovers after drinking have been developed, but due to their toxicity or side effects, much attention has been drawn to the development of safer natural-derived health drinks.
이에 따라, 천연식물 추출물을 이용한 숙취해소용 조성물에 대한 특허 출원이 많아지는 추세이다.Accordingly, there is a trend of increasing patent applications for hangover composition using natural plant extracts.
대한민국공개특허 10-2006-0017559호에서는 산삼 배양근, 곶감, 갈근, 오미자, 생강 추출액을 이용한 숙취해소용 차가 개시되어 있으며,Korean Unexamined Patent Publication No. 10-2006-0017559 discloses a hangover tea using wild ginseng culture root, dried persimmon, brown root, Schisandra chinensis, ginger extract,
대한민국공개특허 10-2006-0095038호에서는 사철쑥, 수분초, 근채, 노근, 모려분 추출물을 이용한 숙취해소용 음료조성물이 개시되어 있고,Republic of Korea Patent Publication No. 10-2006-0095038 discloses a drink composition for hangover elimination using the extract of cedar mugwort, moisture grass, root vegetables, old root, seedlings,
대한민국공개특허 10-2007-0101443호에서는 헛개나무 열매, 인진호, 갈근, 진피, 창출, 감초 추출액을 이용한 숙취해소용 조성물이 개시되어 있다.Korean Unexamined Patent Publication No. 10-2007-0101443 discloses a hangover composition using the bark fruit, Injinho, brown root, dermis, creation, licorice extract.
본 발명의 출원인은 약용식물의 단순한 추출물에 비해 약용식물 추출물을 발효시킨 약용식물 추출 발효물의 숙취해소효과가 더 크다는 것을 확인하여 본 발명을 완성하였다.Applicant of the present invention has completed the present invention by confirming that the hangover relief effect of the medicinal plant extract fermentation fermented medicinal plant extract is greater than the simple extract of the medicinal plant.
본 발명의 목적은 인체에 부작용이 없으면서, 알코올 탈수소효소(Alcohol dehydrogenase, ADH) 활성을 저해하면서 알데하이드 탈수소효소(Aldehyde dehydrogenase, ALDH) 활성을 촉진하여 숙취해소효과가 뛰어난 약용식물 추출 발효물을 유효성분으로 함유하는 숙취 예방 또는 해소용 조성물 및 제조방법을 제공하는 데 있다.It is an object of the present invention to inhibit ethanol dehydrogenase (ADH) activity while promoting the aldehyde dehydrogenase (ALDH) activity while inhibiting the alcohol dehydrogenase (ADH) activity active ingredient extract medicinal plants excellent in hangover It is to provide a composition and manufacturing method for preventing or eliminating hangover.
상기 목적을 달성하기 위해서, 본 발명은 다음과 같은 해결수단을 제공한다.In order to achieve the above object, the present invention provides the following solution.
본 발명은 숙취해소에 효과가 있는 약용식물을 물, C1-C3 알코올 또는 그 혼합물로 추출 후 감압 농축하여 추출액을 제조하는 단계 (단계 1);The present invention water medicinal plants that are effective in relieving hangover, C 1 -C 3 Extracting with alcohol or a mixture thereof and then concentrating under reduced pressure to prepare an extract (step 1);
상기 추출액에 국균 함유 조성물을 첨가하여 당화과정을 거쳐서 당화된 추출액을 얻는 단계 (단계 2); 및Adding a bacterium-containing composition to the extract to obtain a saccharified extract through a saccharification process (step 2); And
상기 당화된 추출액을 젖산균으로 발효하여 발효액을 얻는 단계 (단계 3)를 포함하는 제조방법에 의해 제조되는 약용 식물 추출 발효물을 유효성분으로 함유하는 숙취 예방 또는 해소용 조성물을 제공한다.It provides a composition for preventing or relieving hangover containing the medicinal plant extract fermented product prepared by the manufacturing method comprising the step of fermenting the saccharified extract with lactic acid bacteria (step 3).
상기 단계 1의 약용식물은 숙취해소에 효과가 있는 약용식물은 제한 없이 이 용할 수 있으며, 바람직하게는 감초, 갈근, 구기자, 맥문동, 백봉령, 속새, 오가피, 인진쑥, 작약, 지구자, 차전초 및 홍삼으로 구성된 군으로부터 선택된 하나 이상을 포함하는 것이 바람직하다.The medicinal plants of
상기 단계 1의 추출은 일반적으로 알려져 있는 추출방법을 사용할 수 있으며, 추출 용매로는 물, C1-C3 알코올 또는 그 혼합물을 사용할 수 있으며, 바람직하게는 물을 추출 용매로 사용한다.Extraction of the
상기 추출에 있어서, 추출 조건에는 특별한 제한은 없으며 일반적인 중탕법을 사용할 수 있다. 물을 용매로 사용하여 추출할 때 물의 양에는 특별히 제한이 없으나, 추출 온도 및 시간을 고려할 때 약용식물 중량에 대하여 5 내지 40 배를 사용할 수 있고, 추출 조건은 80 내지 100 ℃의 온도에서 12 내지 72 시간 동안 추출할 수 있다.In the extraction, the extraction conditions are not particularly limited, and a general water bath method can be used. When extracting using water as a solvent, there is no particular limitation on the amount of water, but considering the extraction temperature and time, 5 to 40 times the weight of the medicinal plant can be used, and the extraction conditions are 12 to 12 at a temperature of 80 to 100 ℃. It can be extracted for 72 hours.
상기 단계 2의 당화과정은 누룩을 추출액 100 중량부에 대하여 1 내지 10 중량부 첨가할 수 있고, 15 내지 55 ℃ 에서 36 내지 72 시간 동안 수행될 수 있다.The saccharification process of step 2 may be added 1 to 10 parts by weight with respect to 100 parts by weight of the Nuruk, it may be carried out at 15 to 55 ℃ for 36 to 72 hours.
상기 단계 3의 발효는 15 내지 55 ℃ 에서 1 내지 10 일 동안 수행될 수 있다.Fermentation of
또한, 상기 목적을 달성하기 위해서, 본 발명은 In addition, in order to achieve the above object, the present invention
숙취해소에 효과가 있는 약용식물을 물, C1-C3 알코올 또는 그 혼합물로 추출 후 감압 농축하여 추출액을 제조하는 단계 (단계 1);Extracting a medicinal plant effective in relieving hangover with water, C 1 -C 3 alcohol or a mixture thereof, and then concentrating under reduced pressure to prepare an extract (step 1);
상기 추출액에 국균 함유 조성물을 첨가하여 당화과정을 거쳐서 당화된 추출액을 얻는 단계 (단계 2);Adding a bacterium-containing composition to the extract to obtain a saccharified extract through a saccharification process (step 2);
상기 당화된 추출액을 젖산균으로 발효하여 발효액을 얻는 단계 (단계 3);Fermenting the saccharified extract with lactic acid bacteria to obtain a fermentation broth (step 3);
를 포함하는 약용식물 추출 발효액의 제조방법을 제공한다.It provides a method of producing a medicinal plant extract fermentation broth comprising a.
본 발명에 따른 조성물은 별도의 부형제 없이 원액 그대로 이용가능하며, 이때 원액을 물 등에 그대로 희석하여 섭취하는 것도 가능하다. 한편, 본 발명에 따른 조성물은 음료, 은단 형태의 환, 분말, 정제 등 다양한 형태로 제조될 수 있다.상기 발효물을 일반 식품에 첨가하여 제조하는 것도 가능하다. 환으로 제조시에는 부형제 없이 발효물만으로 제조하는 것도 가능하며 다양한 첨가보조제와 함께 제조하는 것도 가능하다.The composition according to the present invention can be used as it is without a separate excipient, in which case it is also possible to dilute and ingest the stock solution as water. On the other hand, the composition according to the present invention can be prepared in various forms, such as beverages, drops in the form of powder, tablets, etc. It is also possible to prepare the addition of the fermented product to general food. In the case of the manufacture of the ring can be prepared only with fermentation without excipients, it can also be prepared with various additives.
본 발명에 따른 약용식물 추출 발효물을 유효성분으로 함유하는 숙취 예방 또는 해소용 조성물은 인체에 부작용이 없으면서, 알코올 탈수소효소(Alcohol dehydrogenase, ADH) 활성을 저해하면서 알데하이드 탈수소효소(Aldehyde dehydrogenase, ALDH) 활성을 촉진하는 효과가 있다.Hangover prevention or remedy composition containing medicinal plant extract fermentation according to the present invention as an active ingredient has no side effects on the human body, while inhibiting the alcohol dehydrogenase (Alcohol dehydrogenase, ADH) activity while aldehyde dehydrogenase (Aldehyde dehydrogenase, ALDH) It has the effect of promoting activity.
따라서, 숙취의 주요 원인으로 알려진 혈중 아세트알데하이드의 농도를 감소시킴으로써 알코올 섭취 후 나타나는 유해한 신체적, 정신적 증상을 감소시킬 수 있는 효과가 있다. 한편, 본 발명에 따른 약용식물 추출 발효물을 유효성분으로 함 유하는 숙취 예방 또는 해소용 조성물의 경우, 발효를 통하여서 맛에 있어서도 기호도가 향상되는 효과가 있다.Thus, by reducing the concentration of acetaldehyde in the blood known as a major cause of hangover, there is an effect that can reduce the harmful physical and mental symptoms appearing after alcohol consumption. On the other hand, in the case of a hangover prevention or remedy composition containing the medicinal plant extract fermentation according to the present invention as an active ingredient, there is an effect of improving the taste in the taste through fermentation.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에 따른 숙취 해소 또는 예방용 조성물에 대해여 설명한다.The hangover relief or prevention composition according to the present invention will be described.
본 발명에 따른 숙취 해소 또는 예방용 조성물은 다음과 같은 제조방법에 따라서 제조되는 약용식물 추출 발효물을 유효성분으로 함유한다.Hangover relief or prophylactic composition according to the present invention contains a medicinal plant extract fermented product prepared according to the following manufacturing method as an active ingredient.
상기 약용식물 추출 발효물은 숙취해소에 효과가 있는 약용식물을 물, C1-C3 알코올 또는 그 혼합물로 추출 후 감압 농축하여 추출액을 제조하는 단계 (단계 1);The medicinal plant extract fermented medicinal plants that are effective in relieving hangovers, C 1 -C 3 Extracting with alcohol or a mixture thereof and then concentrating under reduced pressure to prepare an extract (step 1);
상기 추출액에 국균 함유 조성물을 첨가하여 당화과정을 거쳐서 당화된 추출액을 얻는 단계 (단계 2); 및Adding a bacterium-containing composition to the extract to obtain a saccharified extract through a saccharification process (step 2); And
상기 당화된 추출액을 젖산균으로 발효하여 발효액을 얻는 단계 (단계 3)를 포함하는 제조방법에 의해 제조될 수 있다.Fermenting the saccharified extract with lactic acid bacteria can be prepared by a manufacturing method comprising the step (step 3) to obtain a fermentation broth.
이하 상기 단계 1을 상세히 설명한다.Hereinafter,
상기 숙취해소에 효과가 있는 약용식물은 이미 숙취해소에 효과가 있는 것으 로 알려진 약용식물을 포함하여 숙취해소에 효과가 있는 모든 약용식물을 제한없이 사용할 수 있다. 상기 약용식물은 감초, 갈근, 구기자, 맥문동, 백봉령, 속새, 오가피, 인진쑥, 작약, 지구자, 차전초 및 홍삼으로 구성된 군으로부터 선택된 하나 이상을 포함하는 것이 바람직하다. 상기 약용식물이 감초, 갈근, 구기자, 맥문동, 백봉령, 속새, 오가피, 인진쑥, 작약, 지구자, 차전초 및 홍삼을 모두 포함하는 경우, 상기 단계 1의 약용식물은 감초 1 내지 10 중량부, 갈근 10 내지 30 중량부, 구기자 5 내지 15 중량부, 맥문동 1 내지 10 중량부, 백봉령 1 내지 10 중량부, 속새 5 내지 15 중량부, 오가피 5 내지 15 중량부, 인진쑥 5 내지 15 중량부, 작약 1 내지 10 중량부, 지구자 1 내지 10 중량부, 차전초 1 내지 10 중량부 및 홍삼 1 내지 20 중량부를 포함하는 것이 바람직하다.The medicinal plants that are effective in relieving hangovers can be used without limitation for all medicinal plants that are effective in relieving hangover, including medicinal plants that are known to be effective in relieving hangovers. The medicinal plants preferably include one or more selected from the group consisting of licorice, brown root, gojija, Mcmundong, Baekbongyeong, genus, Ogapi, jinjin mugwort, peony, earth, chajeoncho and red ginseng. When the medicinal plants include licorice, brown root, wolfberry, macmundong, baekbongryeong, genus, Ogapi, jinjin mugwort, peony, earth, chajeoncho and red ginseng, the medicinal plants of the
상기 조성비는 알코올 분해효소 활성도를 극대화할 수 있는 최적의 조성비를 찾기 위한 ADH 및 ALDH 실험을 통해 도출되었다. 한편, 상기 약용식물은 한약재상들을 통해 구입할 수 있으며, 자연에서 직접 채취하여 사용시에는 감초는 뿌리, 갈근은 뿌리, 구기자는 열매, 맥문동은 뿌리, 백봉령은 뿌리, 속새는 뿌리, 오가피는 외피, 인진쑥은 줄기, 잎 또는 그 혼합, 작약은 뿌리, 지구자는 열매, 차전초는 전체, 홍삼은 뿌리를 사용한다.The composition ratio was derived through ADH and ALDH experiments to find the optimal composition ratio that can maximize the alcoholase activity. On the other hand, the medicinal plants can be purchased through herbal medicines, when used directly in nature, licorice roots, roots roots, roots of goji berries, fruit berries, makmundong roots, roots of Baekbongryeong, roots of the inner ear, the skin of the Ogapi, Injin mugwort Silver stems, leaves, or a mixture thereof, peony roots, earthly fruit, chajeoncho whole, red ginseng root.
상기 단계 1에서 약용식물의 추출은 통상적인 추출방법을 따라서 이루어지며, 추출 용매로는 물이 바람직하다. 추출 조건은 특별히 제한되지는 않으며 일반적인 추출 조건을 당업자가 임의로 선택하여 사용할 수 있으며, 예로서 80 내지 100 ℃의 온도에서 12 내지 72 시간 동안 추출할 수 있다. 물을 사용하여 추 출하는 경우 예로서 약용식물 중량에 대해서 5 내지 40 배를 사용하여 추출할 수 있다. 상기 단계 1의 추출액 제조 단계는 추출액 자체를 그대로 다음 단계에 사용할 수도 있으나, 일반적인 감압 농축 과정을 거쳐 농축된 추출액을 다음 단계에서 사용할 수도 있다. 농축을 통해서 다음 단계의 발효 과정에 사용되는 반응기의 용적을 줄이는 이점을 얻을 수 있다. 농축을 하는 경우 농도는 2.5 내지 15 °Bx (Brix)의 농도까지 농축하는 것이 적당하다.Extraction of medicinal plants in
이하 약용식물의 추출 발효물 제조방법에 있어서 단계 2를 상세히 설명한다. 단계 2는 상기 단계 1에서 얻어진 추출액을 국균을 포함하는 조성물로 발효하여 당화하는 단계이다. 본 단계는 당화에 의해서 단당류를 생성하고, 이러한 단당류에 의해서 다음 단계에서의 젖산균 발효를 더 쉽게 유도하고자 하는 것이다. 본 단계에 따르는 당화 과정은 본 발명의 추출 발효물 제조방법에 있어서 선택적이며, 따라서 단계 2를 제외하고 단계 3의 젖산균 발효과정으로 넘어갈 수도 있다. 본 당화과정은 약용식물에 함유되어 있는 전분 등의 다당체에 대한 발효를 돕기 위한 과정이다.Hereinafter, step 2 will be described in detail in a method of preparing extract fermentation of medicinal plants. Step 2 is a step of fermentation and saccharification of the extract obtained in
상기 단계 2의 당화과정에 사용되는 국균을 포함하는 조성물은 누룩곰팡이를 포함하는 조성물이 바람직하며 통상적으로 누룩을 사용할 수 있다. 사용하는 국균을 포함하는 조성물의 양은 특별히 제한은 없으나 단계 1에서 제조된 추출액 100 중량부에 대하여 1 내지 10 중량부 첨가할 수 있으며, 당화 조건 역시 특별한 제한은 없으나 15 내지 55 ℃의 온도에서 12시간 이상 동안 수행할 수 있으며, 바람직 하게는 국균 함유 조성물은 1 내지 5 중량부를 첨가한다. 당화된 추출액에서의 환원당의 함량은 당화 시간에 따라 증가하며, 36시간 이상에서는 일정한 환원당 농도를 보인다. 한편, 60시간 이상 당화하는 경우에는 당의 함량이 감소하는 경우도 있으며 그 이상의 시간을 발효시키는 것은 의미가 없는바, 당화는 36시간 내지 60시간의 범위에서 실시하는 것이 적당하다.The composition containing the bacterium used in the saccharification process of step 2 is preferably a composition containing yeast mold, and can be used as a conventional yeast. The amount of the composition containing the bacterium used is not particularly limited, but may be added in an amount of 1 to 10 parts by weight based on 100 parts by weight of the extract prepared in
상기 단계 3은 단계 1에서 얻은 추출액 또는 단계 2에서 얻은 당화된 추출액을 젖산 발효하는 과정이다. 본 단계에 사용되는 젖산균은 일반적으로 젖산균으로 총칭되는 젖산을 생산해내는 모든 균을 사용할 수 있으며, 락토바실러스속, 스트렙토코커스속, 페디오코커스속, 류코노스톡속 또는 비피도박테리움속과 같은 젖산균을 사용할 수 있다. 구체적으로는 Lac . bulgaricus, Strepto . lactis, Bifido . bifidum, Leuc . lactis, Lac . delbruechii, Leuc . mesenteroides 와 같은 균주를 사용할 수 있다. 본 단계의 발효 조건은 특별히 제한되지는 않으나, 일예로서 15 내지 55 ℃의 온도에서 1 내지 15 일 동안 수행할 수 있다. 발효기간은 바람직하게는 1 내지 10일, 더욱 바람직하게는 2 내지 10일 동안 수행할 수 있다. 본 단계에 사용되는 젖산균의 함량은 당업자가 적절히 선택하여 조절할 수 있다.
이하 실시예를 통하여 본 발명을 설명한다. 본 실시예는 발명의 이해를 돕기 위한 하나의 예일 뿐이며, 본 실시예에 의해서 본 발명의 범위가 부당하게 제한 해 석되어서는 안 된다.The present invention will be described through the following examples. This embodiment is only one example for aiding the understanding of the present invention, and the scope of the present invention should not be unduly limited by the present embodiment.
실시예Example 1-6. 약용식물 추출 1-6. Medicinal Plant Extracts 발효물의Fermented product 제조 Produce
단계 1. 약용식물 추출액 제조
감초 5g, 갈근 20g, 구기자 10g, 맥문동 5g, 백봉령 5g, 속새 10g, 오가피 10g, 인진쑥 10g, 작약 5g, 지구자 5g, 차전초 5g 및 홍삼 10g을 혼합하고, 혼합물 100g에 20배 중량의 물을 가한 후 90℃의 온도에서 48시간 추출한 후, 감압 농축하여 최종 추출액이 10 °Bx가 되도록 하여 다음 단계에서 사용할 추출액을 준비하였다.Licorice 5g, 20g root, 20g wolfberry 10g, Mcmundong 5g, Baekbongryeong 5g, 10g ginseng, 10g, 10g ginseng, ginseng 10g, peony 5g, earthen 5g, chajeoncho 5g and red ginseng 10g, 20g weight of 100g mixture After extraction for 48 hours at a temperature of 90 ℃, and concentrated under reduced pressure so that the final extract is 10 ° Bx to prepare an extract to be used in the next step.
단계 2. Step 2. 당화된Glycosylated 추출액의 제조 Preparation of Extract
단계 1의 약용식물 추출액 100g에 (주)중앙곡자(충남 공주 소재)에서 제조한 개량누룩(경인식약청 제29호) 3g을 첨가하여 35℃에서 72시간 당화시켰다. To 100 g of the medicinal plant extract of
단계 3.
약용식물 추출액의 발효에 사용되는 미생물 중 6종을 선택하여 MRS broth 배지에 접종 배양하여 단계 2를 거친 당화된 추출액을 대상으로 젖산 발효를 하였다. 선택한 6종의 미생물은 아래 표 1과 같다.Six kinds of microorganisms used for fermentation of medicinal plant extracts were selected and inoculated and cultured in MRS broth medium, and lactic acid fermentation was performed on the glycosylated extracts subjected to Step 2. Six microorganisms selected are shown in Table 1 below.
표 1.Table 1.
발효는 모두 35℃에서 10일 동안 이루어졌고, 각각의 균주를 이용한 발효액을 얻었다.Fermentation was all done for 10 days at 35 ℃, to obtain a fermentation broth using each strain.
실험예Experimental Example 1. 25가지 약용식물에 대한 알코올 탈수소효소( 1. Alcohol dehydrogenase against 25 medicinal plants ADHADH ) 및 ) And 알데하이드Aldehyde 탈수소효소( Dehydrogenase ( ALDHALDH ) 활성도 실험Activity experiment
실시예에서 사용된 감초 이하 홍삼의 12가지 약용식물은 최신방약약합편, 임상본초학의 한의서를 조사하여, 항산화력과 알코올 탈수소효소에 대한 저해성이 있는 것으로 알려진 약용식물 25종을 선별한 후, 알코올 탈수소효소 및 알데하이드 탈수소효소 활성 실험을 거쳐서 선별되었다.Twelve medicinal plants of red ginseng and less than the licorice used in the examples were examined by the latest herbal medicine, the herbal medicine of clinical herbal medicine, and then selected 25 kinds of medicinal plants known to be antioxidant and inhibitory to alcohol dehydrogenase, Screening was carried out through alcohol dehydrogenase and aldehyde dehydrogenase activity experiments.
상기 선별된 25종의 약용식물은 아래의 표 2와 같다.The 25 selected medicinal plants are shown in Table 2 below.
표 2.Table 2.
상기 표 2의 25종의 약용식물을 70mesh의 입자로 분쇄하여 분말화한 후 실험재료로 사용하였다.25 kinds of medicinal plants in Table 2 were pulverized into 70mesh particles and used as experimental materials.
각각의 건조분말 10g에 20배의 증류수를 가하여 80 ~ 90 ℃ 온도의 수욕조에서 환류냉각기를 부착하여 5 ~ 7 시간 추출한 다음 여과하여 얻어진 여액을 감압 농축하여 추출액을 100㎖로 정용한 후 효소활성도 측정 시료로 사용하였다. 20 g of distilled water was added to 10 g of each dry powder, and a reflux condenser was attached in a water bath at 80-90 ° C. for 5 to 7 hours. The filtrate was filtered and concentrated under reduced pressure. Used as a sample.
상기 25가지 약용식물 추출액에 대한 알코올 분해효소 활성도 실험을 실시하였다.The alcohol degrading enzyme activity of the 25 medicinal plant extracts was conducted.
ADH(Sigma A7011-30KU), ALDH(Sigma 82884) 및 NAD+(Sigma 43407)는 Sigma사(Sigma chemical, co., USA)에서 구입하여 사용하였다.ADH (Sigma A7011-30KU), ALDH (Sigma 82884) and NAD + (Sigma 43407) were purchased from Sigma (Sigma chemical, co., USA) and used.
ADHADH 활성도 측정 Activity measurement
ADH 활성도는 분광광도계를 이용하여 340㎚에서 형성되는 NADH의 흡광도를 측정하여 활성도를 표시하였다. 즉 시험관에 에탄올 0.1㎖, NAD 수용액(2㎎/㎖) 0.5㎖, 각각의 약용식물추출액 0.1㎖를 첨가하고 0.01 M glycine-NaOH buffer 용액(pH 8.8)을 총부피가 1.8㎖이 되도록 첨가한 후 25℃ 항온조에서 10분간 반응시키고, ADH(18 unit/㎖) 0.25㎖를 가하여 340㎚에서 흡광도의 변화를 측정하였다. 이 때 대조구는 ADH 대신 0.01 M glycine-NaOH buffer 용액 0.25㎖를 넣은 것으로 하였다. ADH의 활성은 반응 종료 시의 최대 흡광도를 대조구의 최대흡광도에 대한 상대적인 활성도(%)를 구하였으며, 그 결과를 표 3에 나타내었다.ADH activity was measured by measuring the absorbance of NADH formed at 340nm using a spectrophotometer to indicate the activity. That is, 0.1 ml of ethanol, 0.5 ml of NAD solution (2 mg / ml) and 0.1 ml of each medicinal plant extract were added to the test tube, and 0.01 M glycine-NaOH buffer solution (pH 8.8) was added so that the total volume was 1.8 ml. The reaction was carried out in a 25 ° C. thermostat for 10 minutes, and 0.25 ml of ADH (18 units / ml) was added to measure the change in absorbance at 340 nm. In this case, 0.25 ml of 0.01 M glycine-NaOH buffer solution was used instead of ADH. In the activity of ADH, the maximum absorbance at the end of the reaction was determined relative to the maximum absorbance of the control (%), the results are shown in Table 3.
ALDHALDH 활성도 측정 Activity measurement
ALDH의 활성도는 NADH 생성에 따른 흡광도의 변화를 340㎚에서 측정하였다. ALDH의 활성도 측정을 위해 50 mM sodium pyrophosphate buffer 용액(pH 8.8), 0.5 mM NAD, 0.1 mM pyrazole, 5 mM acetaldehyde인 반응액 2.25㎖에 0.1㎖ ALDH(1 unit/㎖)와 약용식물추출액 0.1㎖을 첨가한 후, 25℃ 항온조에서 10분간 방치하고 340㎚에서 흡광도를 측정하였으며 ALDH의 활성은 ADH의 활성과 같은 방법으로 표시하여, 그 결과를 표 3에 나타내었다.The activity of ALDH was measured at 340 nm in the change of absorbance according to NADH production. To measure the activity of ALDH, 0.1 ml of ALDH (1 unit / ml) and 0.1 ml of medicinal plant extract were added to 2.25 ml of 50 mM sodium pyrophosphate buffer solution (pH 8.8), 0.5 mM NAD, 0.1 mM pyrazole, and 5 mM acetaldehyde. After the addition, the mixture was left for 10 minutes in a 25 ° C. thermostat and absorbance was measured at 340 nm. The activity of ALDH was expressed by the same method as that of ADH, and the results are shown in Table 3.
표 3.Table 3.
상기 실험에 따라, ADH 저해 활성이 높으면서 ALDH 촉진 활성이 높은 약용식물 12가지를 선별하여 표 4에 나타내었다.According to the experiment, 12 medicinal plants with high ADH inhibitory activity and high ALDH promoting activity were selected and shown in Table 4.
표 4.Table 4.
실험예Experimental Example 2. 약용식물 추출 발효액의 유산균에 따른 2. Lactic Acid Bacteria of Medicinal Plant Extract Fermentation Broth ADLADL 활성도 및 Activity and ALDHALDH 활성 측정Active measurement
실시예 1 내지 6으로부터 얻은 발효액에 대해 ADH 저해 활성 및 ALDH 촉진 활성을 측정하여 표 5에 나타내었다. 실험 방법은 실험예 1과 동일하게 하였다.The fermentation broth obtained from Examples 1 to 6 was measured in ADH inhibitory activity and ALDH promoting activity is shown in Table 5. The experimental method was the same as that of Experimental example 1.
표 5.Table 5.
표 5에서 확인할 수 있듯이, 6종의 유산균 중에서는 Lactobacillus delbruechii sub . sp . lactis (KCTC 3636) 균이 ADH 저해활성 및 ALDH 활성이 가장 뛰어난 것으로 확인되었다.As can be seen in Table 5, among the six lactic acid bacteria Lactobacillus delbruechii sub . sp . lactis (KCTC 3636) was found to have the best ADH inhibitory activity and ALDH activity.
실험예Experimental Example 3. 약용식물 추출액 및 그 3. Medicinal plant extract and its 발효물에Fermented products 대한 About ADHADH , , ALDHALDH 비교 compare
실시예 5의 단계 1에서 얻은 약용식물 추출액(CMHE)과 실시예 5의 단계 3까지 거쳐 얻은 약용식물 추출 발효액(FCMHE)에 대하여 ADH와 ALDH 효소활성을 측정하여 표 6에 나타내었다. 측정 방법은 실험예 1의 방법과 동일하게 하였다.The medicinal plant extract (CMHE) obtained in
표 6.Table 6.
표 6을 보면, 약용식물 추출물에서는 ADH 활성이 -20.22% 인데 비하여 약용식물 추출 발효물은 -62.63% 로서 ADH 저해활성이 높았으며, ALDH 활성은 약용식물 추출물에서는 173.20% 이었으며, 약용식물 추출 발효물은 280.17%로 ALDH 촉진 활성이 추출물보다 약 1.6배가 증가됨을 알 수 있었다. 이러한 결과는 미생물에 의한 발효과정을 통하여 생성되는 발효산물이 숙취해소 효과에 영향을 주기 때문으로 해석된다.In Table 6, ADH activity was -20.22% in medicinal plant extracts, whereas ADH inhibitory activity was -62.63% in medicinal plant extracts, and ALDH activity was 173.20% in medicinal plant extracts. Silver 280.17% ALDH promoting activity was found to increase about 1.6 times than the extract. These results are interpreted as the fermentation products produced through the fermentation process by microorganisms affect the hangover removal effect.
실험예Experimental Example 4. 흰쥐에 대한 약용식물 추출 4. Medicinal Plant Extracts from Rats 발효물의Fermented product 숙취해소효과 Hangover Relief
체중 80~100g의 생후 4주령 Sprague-Dawley(SD) 수컷 흰쥐 48마리를 다물사이언스(한국)에서 구입하여 2주일간 고형배합사료와 물로 예비 사육시킨 후 체중이 23-~240g에 도달했을 때 군을 재분리한 후 실험을 수행하였다. 추출 발효물의 알코올성 숙취에 미치는 영향을 알아보기 위해서 알코올 섭취 후 시간경과에 따른 혈중 알코올 농도와 아세트알데히드 농도를 측정하였다. 증류수를 투여한 대조군과 실시예 5에 따른 추출 발효물을 50, 100, 200, 400 ㎎/㎏ 씩 투여한 실험군, 시판 숙취해소음료(컨디션)를 5㎖/㎏로 투여한 양성대조군(PC, positive control)군의 6군으 로 군당 8마리씩 나누어 수행하였다. 각 군에 대하여 시료를 1회 경구투여하고, 30분이 경과한 다음 20% 에탄올(15㎖/㎏)을 경구 투여하였다. 이 후 1, 3, 5, 7 시간 후에 혈중 알코올 농도와 아세트알데히드 농도를 측정하였다. 사육실의 온도는 23±1℃, 습도 50±5%로 유지하였고, 12시간 명암주기를 유지하였다. 사육기간 동안 물과 식이는 자유롭게 섭취케 하였다.48 male Sprague-Dawley (SD) male rats, weighing 80-100 g, were purchased from Damul Science (Korea) and pre-stocked with solid feed and water for 2 weeks, then weighed at 23-240 g. Experiments were performed after reseparation. In order to investigate the effects of extract fermentation on alcoholic hangover, blood alcohol concentration and acetaldehyde concentration were measured over time after alcohol intake. A control group administered with distilled water and an experimental group administered 50, 100, 200, 400 mg / kg each of the extract fermentation products according to Example 5, and a positive control group (PC, administered with a commercial hangover drink (condition) at 5 ml / kg) Six groups of positive control group were divided into 8 groups. Samples were administered orally once for each group, and after 30 minutes, 20% ethanol (15 mL / kg) was orally administered. After 1, 3, 5, and 7 hours, blood alcohol and acetaldehyde levels were measured. The temperature of the feeding room was maintained at 23 ± 1 ℃,
표 7.Table 7.
알코올 투여 후 1, 3, 5, 7 시간 후에 흰쥐의 경동맥에서 혈액을 채취하여 실온에서 30분간 방치 후 1,500 rpm 에서 15분간 원심분리하여 상층액을 분리하였다. 0.3 M potassium phosphate buffer (pH 9) 290㎕와 0.049 M NAD+ 100㎕를 혼합한 후 시료 혈액 샘플 100㎕를 첨가하여 20℃에서 3분간 놓아둔 후 340㎚에서 흡광도를 측정하였다 (A1). 또한 이상의 혼합액에 ADH 또는 ALDH 50㎕를 첨가하여 20℃에서 5분간 놓아둔 후 340㎚ 에서 흡광도를 측정하였다 (A2). 이를 바탕으로 혈중 알코올의 농도는 아래의 공식에 의해 정량하였다.After 1, 3, 5, and 7 hours of alcohol administration, blood was collected from the carotid artery of the rat, left at room temperature for 30 minutes, and centrifuged at 1,500 rpm for 15 minutes to separate the supernatant. After mixing 290 μl of 0.3 M potassium phosphate buffer (pH 9) and 100 μl of 0.049 M NAD +, 100 μl of the sample blood sample was added thereto, and the absorbance was measured at 340 nm after 3 min at 20 ° C. (A1). In addition, 50 µl of ADH or ALDH was added to the above mixture, and the resultant was kept at 20 ° C for 5 minutes, and the absorbance was measured at 340 nm (A2). Based on this, the concentration of blood alcohol was quantified by the following formula.
알코올 농도(Concentration) = 0.7259/3.6×△AConcentration = 0.7259 / 3.6 × ΔA
△A = sample (A2 - A1) - blank (A2 - A1)ΔA = sample (A2-A1)-blank (A2-A1)
시험결과는 평균±표준오차로 표시하고, 일원배치분산분석(one-way analysis of variance, ANOVA)을 실시하여 유의성이 관찰되면 대조군과의 유의적인 차이가 있는 시험군을 알아내기 위해 Dunnett test를 실시하였다.The test results are expressed as mean ± standard error, and one-way analysis of variance (ANOVA) is performed. If significance is observed, Dunnett test is performed to find a test group that is significantly different from the control group. It was.
약용식물 추출 발효물의 숙취 개선 효능을 확인하기 위하여 혈중 알코올의 농도를 측정하여 도 1에 나타내었다.In order to confirm the hangover improvement effect of the medicinal plant extract fermentation is shown in Figure 1 by measuring the concentration of alcohol in the blood.
대조군의 경우 1시간 만에 혈중 알코올 농도가 최고치에 도달하였다. 또한, 1시간이 경과하였을 때 혈중 알코올 농도는 추출 발효물 400㎎/㎏ 처리군과 시판 숙취개선음료를 공급한 군에서 대조군에 비하여 35.8% 정도의 유의적인 감소를 보였다. 알코올 섭취 후 3시간에서는 추출 발효액 400㎎/㎏ 처리군이 시판 숙취개선음료 처리군보다 24.1% 정도 우수한 효능을 보였다.In the case of the control group, the blood alcohol concentration reached the highest level in 1 hour. In addition, after 1 hour, the blood alcohol concentration was significantly decreased by 35.8% in the extract fermented 400 mg / kg treatment group and the commercial hangover treatment group compared to the control group. At 3 hours after alcohol intake, the fermented
또한 혈중 아세트알데하이드 농도를 측정하여 도 2에 나타내었다.In addition, blood acetaldehyde concentration is measured and shown in FIG. 2.
대조군의 경우 혈중 아세트알데하이드 농도는 5시간 경과 후에 최고치에 달하였다가 이 후 완만한 감소를 보인 반면, 추출 발효액과 시판 숙취개선음료를 공급한 군의 경우는 3시간 경과 후 혈중 아세트알데하이드 농도가 최고치에 달하였다가 이후 급격히 감소하는 결과를 보였다. 3시간 경과시부터 7시간까지 혈중 아세트알데하이드의 감소폭은 추출 발효액 50㎎/㎏처리군 -40.7%, 100㎎/㎏처리군 -45.9%, 200㎎/㎏처리군 -49.6%, 400㎎/㎏ 처리군 -65.1%, 시판 숙취개선음료를 공급한 군 -57.5% 로 나타나, 추출발효액 400㎎/㎏ 처리군의 혈중 아세트알데하이드 감소폭이 가장 큰 것으로 나타났다.In the control group, the blood acetaldehyde concentration peaked after 5 hours and then gradually decreased, whereas the blood acetaldehyde concentration peaked after 3 hours in the group fed with fermented broth and commercial hangover beverage. And then decreased rapidly. The reduction of acetaldehyde in blood from 3 hours to 7 hours was 50 mg / kg of the extract fermentation solution -40.7%, -45.9% of the 100 mg / kg treatment group, -45.9% of the 200 mg / kg treatment group, -49.6%, 400 mg / kg. The treatment group -65.1% and the commercial hangover improvement drink -57.5% showed the greatest decrease in blood acetaldehyde in the
따라서 본 연구에서는 추출 발효액의 숙취 개선 효능을 확인하기 위하여 혈중 알코올 농도와 아세트알데하이드 농도를 측정한 결과, 혈중 알코올 농도는 알코올 경구 투여 3시간째 추출 발효액 400㎎/㎏ 처리군이 시판 숙취개선음료 처리군보다도 우수한 효능을 보여 혈중 알코올을 가장 효과적으로 감소시키는 결과를 보였다.Therefore, in this study, the blood alcohol concentration and acetaldehyde concentration were measured to confirm the hangover improvement effect of the extract fermentation broth. It showed better efficacy than the group and showed the most effective reduction of blood alcohol.
또한 혈중 아세트알데하이드의 농도 변화에서도 에탄올 경구 투여 3시간 경과 시부터 혈중 아세트알데하이드의 감소폭은 추출 발효액 50㎎/㎏처리군 -40.7%, 100㎎/㎏처리군 -45.9%, 200㎎/㎏처리군 -49.6%, 시판 숙취개선음료를 공급한 군 -57.5% 에 비해 추출발효액 400㎎/㎏처리군의 감소폭(-65.1%)이 유의적으로 가장 큰 것으로 나타났다. In addition, even after 3 hours of oral administration of ethanol, the decrease in the concentration of acetaldehyde in the blood was changed to 50 mg / kg of the treated fermentation solution -40.7%, -45.9% of the 100 mg / kg treatment group, and -45.9% of the 200 mg / kg treatment group. The decrease in
상기 실험 결과를 볼 때 본 발명의 추출 발효액은 숙취의 주요 원인으로 알려진 혈중 아세트알데하이드의 농도를 감소시킴으로써 알코올 섭취 후 나타나는 유해한 신체적, 정신적 증상을 감소시킬 수 있는 효과가 있음을 확인하였다.As a result of the experiment, it was confirmed that the extract fermentation broth of the present invention has an effect of reducing harmful physical and mental symptoms after alcohol consumption by reducing the concentration of acetaldehyde in blood, which is known as a major cause of hangover.
제조예Production Example 1. One. 은단형태의Hidden 환 제조 Ring manufacturing
실시예 5에서 제조된 발효물을 40 °Bx까지 고농축한 후, 이를 스프레이 드라이어(spray drier)를 이용하여 분말화 한 다음 유동층 코팅기를 이용하여 부형제 없는 은단형태의 환을 제조하였다. 구체적으로는 고농축된 발효물을 60℃의 온도로 가온한 후 170℃의 온도에서 흡입하고 95℃의 온도로 배출하여 코팅하기에 적당한 양만큼 분무건조를 행하여 분말을 얻었다. 다음 제품 온도를 75℃의 온도로 유지한 다음 노즐압력 2.0 ~ 3.0 bar로 분무하면서 일정크기의 환이 되도록 코팅하여 은단형태의 환을 제조하였다.The fermentation product prepared in Example 5 was highly concentrated to 40 ° Bx, and then powdered by using a spray drier, and then an excipient-free silver ring was prepared using a fluidized bed coater. Specifically, the highly concentrated fermented product was heated to a temperature of 60 ° C., suctioned at a temperature of 170 ° C., discharged to a temperature of 95 ° C., and spray-dried in an amount suitable for coating to obtain a powder. Next, the product temperature was maintained at a temperature of 75 ° C and then sprayed at a nozzle pressure of 2.0 ~ 3.0 bar was coated to a ring of a certain size to prepare a ring in the form of silver.
도1는 실험예 흰쥐의 혈중 알코올 농도를 나타내는 그래프.1 is a graph showing the blood alcohol concentration of experimental rats.
도2은 흰쥐의 혈중 아세트알데하이드 농도를 나타내는 그래프.2 is a graph showing the acetaldehyde concentration in the blood of rats.
<도면의 부호의 설명><Explanation of symbols in the drawings>
EtOH : 대조군 (증류수 + 에탄올)EtOH: control (distilled water + ethanol)
HE-50 : 실시예 5에 따른 추출 발효물 50㎎/㎏ + 에탄올HE-50:
HE-100 : 실시예 5에 따른 추출 발효물 100㎎/㎏ + 에탄올HE-100: 100 mg / kg extract fermentation according to Example 5 + ethanol
HE-200 : 실시예 5에 따른 추출 발효물 200㎎/㎏ + 에탄올HE-200: 200 mg / kg extract fermentation according to Example 5 + ethanol
HE-400 : 실시예 5에 따른 추출 발효물 400㎎/㎏ + 에탄올HE-400: Extracted
PC : 양성대조군(시판 숙취해소음료(컨디션)+ 에탄올)PC: Positive control group (commercial hangover drink (condition) + ethanol)
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090065263A KR100963227B1 (en) | 2009-07-17 | 2009-07-17 | Composition containing fermented extract of medicinal plant for prevention or relief of alcoholic hangover and manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090065263A KR100963227B1 (en) | 2009-07-17 | 2009-07-17 | Composition containing fermented extract of medicinal plant for prevention or relief of alcoholic hangover and manufacturing method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100963227B1 true KR100963227B1 (en) | 2010-06-16 |
Family
ID=42369959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090065263A KR100963227B1 (en) | 2009-07-17 | 2009-07-17 | Composition containing fermented extract of medicinal plant for prevention or relief of alcoholic hangover and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100963227B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101281988B1 (en) | 2010-06-23 | 2013-07-03 | (주)새롬바이오 | Composition having eleutherococcus senticosus for treating hangover and improving liver function, and the preparation method thereof |
KR101344054B1 (en) * | 2012-05-31 | 2013-12-24 | 주식회사 새롬 | Composition for improving liver function containing fermented liquor of Hovenia dulcis Thunb extract as effective component |
KR101489923B1 (en) | 2013-11-25 | 2015-02-05 | 장영창 | An alcohol detoxification beverage comprising extract of natural herb tea and manufacturing method thereof |
KR20170085451A (en) * | 2016-01-14 | 2017-07-24 | 주식회사 프라임오라 | Composition for eliminating hangover |
KR101900667B1 (en) | 2017-01-19 | 2018-09-21 | 계명대학교 산학협력단 | Combined Fermented Broth of Mixed Extraction Oriental Medicine Material, Method for Preparing the Same, and Composition for Health Functional Food or Food Additive Comprising the Same |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060017559A (en) * | 2006-02-09 | 2006-02-23 | 피엔에프생명과학 주식회사 | Tea for curing of hangover and method for manufacture of the same |
-
2009
- 2009-07-17 KR KR1020090065263A patent/KR100963227B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060017559A (en) * | 2006-02-09 | 2006-02-23 | 피엔에프생명과학 주식회사 | Tea for curing of hangover and method for manufacture of the same |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101281988B1 (en) | 2010-06-23 | 2013-07-03 | (주)새롬바이오 | Composition having eleutherococcus senticosus for treating hangover and improving liver function, and the preparation method thereof |
KR101344054B1 (en) * | 2012-05-31 | 2013-12-24 | 주식회사 새롬 | Composition for improving liver function containing fermented liquor of Hovenia dulcis Thunb extract as effective component |
KR101489923B1 (en) | 2013-11-25 | 2015-02-05 | 장영창 | An alcohol detoxification beverage comprising extract of natural herb tea and manufacturing method thereof |
KR20170085451A (en) * | 2016-01-14 | 2017-07-24 | 주식회사 프라임오라 | Composition for eliminating hangover |
KR101894653B1 (en) * | 2016-01-14 | 2018-10-04 | 주식회사 프라임오라 | Composition for eliminating hangover |
KR101900667B1 (en) | 2017-01-19 | 2018-09-21 | 계명대학교 산학협력단 | Combined Fermented Broth of Mixed Extraction Oriental Medicine Material, Method for Preparing the Same, and Composition for Health Functional Food or Food Additive Comprising the Same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101455354A (en) | Natural Juncao liver-nourishing and sobering-up agent | |
KR20110048236A (en) | Compositions for prevention and improvement of cancer containing the extracts of native plants as an active ingredient | |
KR101705545B1 (en) | Composition for preventing respiratorydisease, immune-enhancing, anti-obesity containing fermented Platycodon grandiflorum | |
KR101339706B1 (en) | A compound for immune strengthen inclusion reducing the bitterness of red ginseng, the extract of immune, and the probiotics | |
KR100963227B1 (en) | Composition containing fermented extract of medicinal plant for prevention or relief of alcoholic hangover and manufacturing method thereof | |
KR20130056639A (en) | Health food fermented using effective micro-organisms with herbal medicine for reducing blood sugar and blood pressure and manufacturing method thereof | |
CN110771708A (en) | Preparation method and application of poria cocos mycelium lithocarpus litseifolius fermented tea | |
CN104840778A (en) | Traditional Chinese medicine fermented hair-blacking preparation, preparation method and purpose thereof | |
KR101372400B1 (en) | A manufacturing method of red ginseng staf4h with enhanced trace ginsenoside | |
KR102298700B1 (en) | Facturing method of functional liquefied healthfoods using Gastroia elata Blume and Polygonum multiflorum Thunberg | |
KR20160126591A (en) | Method of producing ginseng fermented extract, Ginseng fermented extract produced by the same and Health functional foods comprising the same | |
KR101282371B1 (en) | Composition for inhibiting differentiation and accumulation of fat cells comprising fermented extract of purple sweet potato as an active ingredient | |
KR20180057754A (en) | Composition comprising fermented extracts having anti-atopic activity | |
KR100848686B1 (en) | A FERMENTED GINSENG COMPOSITION STRENGTHENED SIMULTANEOUSLY WITH γ-AMINOBUTYRIC ACID AND BIOCONVERSION SAPONIN BY LACTIC ACID BACTERIA | |
KR102507651B1 (en) | Fermented Stauntonia hexaphylla for hangover relief, alcoholic liver disease or liver function improvement using fermented enzyme complex solution containing traditional brewery yeast and its manufacturing method | |
KR100991740B1 (en) | Method of Making Buckwheat Wine | |
KR20160052824A (en) | Health beverage using natural materials with protection of brain cells | |
KR20140062230A (en) | Fermented bellflower pills and preparation thereof | |
KR101970320B1 (en) | Composition for preventing, improving or treating respiratory diseases comprising fermented solution of Chaenomeles sinensis as effective component and production method thereof | |
KR20210081649A (en) | Manufacturing method of beverage composition for improving asthma, bronchitis or pneumonia comprising fermented extract of Aster tataricus as effective component | |
KR102668792B1 (en) | Health functional food and pharmaceutical composition to help improve sleep quality | |
KR102365198B1 (en) | Facturing method of functional liquefied healthfoods using Gastroia elata Blume, Polygonum multiflorum Thunberg and mountain ginseng | |
KR102595524B1 (en) | Platycodon grandiflorum fermented product comprising platycodon grandiflorum and rice grain syrup and method for preparing thereof | |
KR20150069174A (en) | Composition for preventing or treating non-alcoholic fatty liver containing Nontoxic fermented extract of Rhus verniciflua as an active ingredient | |
KR20200126839A (en) | Composition for relieving or improving hangover |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130603 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140630 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150601 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170605 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180614 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190329 Year of fee payment: 10 |